Alendronate Sodium
Product Images NDC 54868-5861

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Alendronate Sodium (NDC 54868-5861). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Alendronate Sodium Structural Formula (1752745b 35fd 4b7e B676 Bff3edd7e8ca 01)

FDA Label Image

Figure 1 (1752745b 35fd 4b7e B676 Bff3edd7e8ca 02)

FDA Label Image

Figure 2 (1752745b 35fd 4b7e B676 Bff3edd7e8ca 03)

This is a graph of a study that analyzed the effects of a medication called Alendronate Sodium 10 mg over a period of 36 months. The x-axis represents time (in months), and the y-axis represents the number of participants who had taken the medication. However, without additional context, it is impossible to determine the purpose or results of the study.*

FDA Label Image

Osteoporosis Treatment Studies In Postmenopausal Women Time Course Of Effect Of Alendronate Sodium 10 mg/day Versus Placebo: Lumbar Spine Bmd Percent Change From Baseline (1752745b 35fd 4b7e B676 Bff3edd7e8ca 04)

This is not-available as the provided text consists of only a few numbers and words that do not form a clear description.*

FDA Label Image

Cumulative Incidence Of Hip Fractures In The Three-year Study Of Fit (patients With Radiographic Vertebral Fracture At Baseline) (1752745b 35fd 4b7e B676 Bff3edd7e8ca 05)

FDA Label Image

Osteoporosis Prevention Studies In Postmenopausal Women (1752745b 35fd 4b7e B676 Bff3edd7e8ca 06)

FDA Label Image

Osteoporosis Prevention Studies In Postmenopausal Women (1752745b 35fd 4b7e B676 Bff3edd7e8ca 07)

FDA Label Image

Figure 7 (1752745b 35fd 4b7e B676 Bff3edd7e8ca 08)

FDA Label Image

Studies In Paget's Disease Of Bone Effect On Serum Alkaline Phosphatase Of Alendronate Sodium 40 mg/day Versus Placebo Or Etidronate 400 mg/day (1752745b 35fd 4b7e B676 Bff3edd7e8ca 09)

FDA Label Image

Alendronate Sodium Tablets Usp 35 mg 4s Box (5860)

Not available.*

FDA Label Image

Alendronate Sodium Tablets Usp 70 mg 4s Box (5861)

This is a description of a medication called Lenmronate SO 70 T4BS. It was distributed by Physicians Total Care and has an NDC number of 54868-5861-0. The text also includes a code of 53610040000, but it is unclear what this represents.*

FDA Label Image

Alendronate Sodium Tablets 10 mg 30s Label (5862)

This is a medication label for alendronate sodium with a total of 164g in the bottle. The medication is distributed by Physicians Total Care, and the lot number is 0600 with a expiration date of 61460. The NDC number is 54868-5862-0. However, the last line appears to be random numbers and not an important message.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.